Public Alert No. 36/2025 – WHO Alert on 3 Substandard (contaminated) oral liquid medicines identified in India
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers and the public of three substandard (contaminated) oral liquid medicines identified in India and reported to WHO on 8 October 2025. The contaminated oral liquid medicines have been identified to be specific batches of COLDRIF, Respifresh TR, and ReLife, manufactured […]
Public Alert No. 35/2025 – Substandard batches of Annmox (Amoxicillin suspensions 125mg/5ml) and Jawamox (Amoxicillin suspension 125mg/5ml) manufactured by Jawa International Ltd due to low Active Pharmaceutical Ingredient (API) content
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the mop up of batches of confirmed substandard Annmox (Batch 360M) and Jawamox (Batch 4231M & 4290M) Suspensions. The products failed laboratory analysis due to low Active Pharmaceutical Ingredient (API) content. The company has been directed to recall the failed […]
Public Alert No. 34/2025 –Substandard Astamocil (Amoxicillin Suspension 125mg/5ml), Batch No. 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension), Batch Nos: 0503024 & 0501724, manufactured by Sam-Ace Ltd in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public about the recall of two products: Astamocil (Amoxicillin Suspension 125mg/5ml), Batch 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension 228.5 mg), Batches 0503024 and 0501724, manufactured by Sam-Ace Ltd in Nigeria. The products were discovered by the Agency’s Post Marketing Surveillance Directorate […]
Public Alert No. 033/2025 – Alert on the Sale of Counterfeit Cialis Tablet 20mg in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the distribution and sale of counterfeit Cialis 20mg tablets in Nigeria. Information received from the Marketing Authorization Holder (MAH) shows that the counterfeit version was discovered during a routine market surveillance in Abuja. It was reported that the counterfeit […]
Public Alert No. 032/2025 – Alert on the Discontinuation of the Production of Penicillin-Based Moiety by Miraflash
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the decision to discontinue the production of penicillin-based products by Miraflash Nigeria Limited. This decision is taken as a corrective measure and closure of a critical observation made during a GMP inspection conducted in the company by a team […]
Public Alert No. 031/2025 – Alert on the Presence of an Unauthorized/ Unregistered Darzalex (Daratumumab) 1800mg/15ml vial SC Injection in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) is alerting the public on the sale of an unauthorized and unregistered brand of Daratumumab formulation in Nigeria. An internal investigation conducted by Johnson & Johnson revealed that there are two different packaging designs for their Daratumumab product. One design is intended for the […]
Launch of the Implementation of Strategy and Roadmap for Trans-fatty Acids (TFAs) Regulation
Keynote Speech by Prof. Adeyeye C M, Director General NAFDAC Launch of the Implementation of Strategy and Roadmap for Trans-fatty Acids (TFAs) Regulation 28th September, 2025. Protocol The Coordinating Minister of Health, Federal Ministry of Health and Social Welfare (FMOHSW), ably represented by Director/Head, Food Safety and Quality Programme, Mr. John Atanda World Health Organization (WHO) […]
Updated Public Alert No. 030A/2025 – Sale of Confirmed Substandard ARTEMETRIN DS Tablets
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the sale of confirmed substandard ARTEMETRIN DS Tablets. The ARTEMETRIN DS (Artemether/Lumefantrine) tablet (80mg/480mg) is registered product labelled as manufactured by A.C. DRUGS Ltd, Plot C5/C6 Old Airport Road, Emene, Enugu State, Nigeria. The product is sub-standard. The product […]
Public Alert No. 030B/2025 – Sale of Confirmed Falsified CIPROFIT 500
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the sale of confirmed Falsified CIPROFIT 500 in Nigeria. The CIPROFIT 500 (Ciprofloxacin Tablet USP 500mg) is labelled manufactured by Impact Pharmaceutical Ltd, No. 33A/33B Standard Industrial Layout Emene-Enugu State, Nigeria. However, it is a falsified product. The product […]
Public Alert No. 029/2025 – Notice to Recall Embacef 125 Powder For Oral Suspension
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a notification to Embassy Pharmaceutical and Chemicals Ltd, Lagos (Holder of Registration Certificate) and Laborate Pharmaceutical India, the manufacturer of Embacef 125 Powder for Oral Suspension, to recall its product following a received complaint reporting the caking of two bottles of the […]
